BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 26268150)

  • 1. Optimal threshold of postintervention minimum stent area to predict in-stent restenosis in small coronary arteries: An optical coherence tomography analysis.
    Matsuo Y; Kubo T; Aoki H; Satogami K; Ino Y; Kitabata H; Taruya A; Nishiguchi T; Teraguchi I; Shimamura K; Shiono Y; Orii M; Yamano T; Tanimoto T; Yamaguchi T; Hirata K; Tanaka A; Akasaka T
    Catheter Cardiovasc Interv; 2016 Jan; 87(1):E9-E14. PubMed ID: 26268150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravascular ultrasound assessment of optimal stent area to prevent in-stent restenosis after zotarolimus-, everolimus-, and sirolimus-eluting stent implantation.
    Song HG; Kang SJ; Ahn JM; Kim WJ; Lee JY; Park DW; Lee SW; Kim YH; Lee CW; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2014 May; 83(6):873-8. PubMed ID: 22815193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Difference in vascular response between sirolimus-eluting- and everolimus-eluting stents in ostial left circumflex artery after unprotected left main as observed by optical coherence tomography.
    Fujino Y; Attizzani GF; Tahara S; Naganuma T; Takagi K; Yabushita H; Wang W; Tanaka K; Matsumoto T; Kawamoto H; Yamada Y; Amano S; Watanabe Y; Warisawa T; Sato T; Mitomo S; Kurita N; Ishiguro H; Hozawa K; Tsukahara T; Motosuke M; Bezerra HG; Nakamura S; Nakamura S
    Int J Cardiol; 2017 Mar; 230():284-292. PubMed ID: 28065691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of in-stent neoatherosclerosis and tissue characteristics between early and late in-stent restenosis in second-generation drug-eluting stents: an optical coherence tomography study.
    Sabbah M; Kadota K; El-Eraky A; Kamal HM; Abdellah AT; El Hawary A
    Int J Cardiovasc Imaging; 2017 Oct; 33(10):1463-1472. PubMed ID: 28444549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restenosis After Everolimus-eluting Vascular Scaffolding. Angiographic and Optical Coherence Tomography Characterization.
    Chavarría J; Suárez de Lezo J; Ojeda S; Pan M; Segura J; Mazuelos F; Espejo S; López J; Romero M; Suárez de Lezo J
    Rev Esp Cardiol (Engl Ed); 2017 Jul; 70(7):543-550. PubMed ID: 28132761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials.
    Doi H; Maehara A; Mintz GS; Yu A; Wang H; Mandinov L; Popma JJ; Ellis SG; Grube E; Dawkins KD; Weissman NJ; Turco MA; Ormiston JA; Stone GW
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1269-75. PubMed ID: 20129555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optical coherence tomography study of healing characteristics of paclitaxel-eluting balloons vs. everolimus-eluting stents for in-stent restenosis: the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) randomised clinical trial.
    Adriaenssens T; Dens J; Ughi G; Bennett J; Dubois C; Sinnaeve P; Wiyono S; Coosemans M; Belmans A; D'hooge J; Vrolix M; Desmet W
    EuroIntervention; 2014 Aug; 10(4):439-48. PubMed ID: 25138182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial and late efficacy of everolimus-eluting stents for small and non-small coronary lesions from evaluating delayed late loss study.
    Tama N; Uzui H; Horita Y; Namura M; Tada H
    Heart Vessels; 2017 Dec; 32(12):1415-1423. PubMed ID: 28687988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical characteristics and prognosis of lesions with in-stent eccentric tissue proliferation and strong signal attenuation detected by optical coherence tomography.
    Suzuki N; Kozuma K; Kyono H; Nakaya H; Nishide S; Mitsui M; Nara Y; Kawashima H; Nomura T; Yamamoto H; Sasajima Y; Kondo F; Isshiki T
    Cardiovasc Interv Ther; 2016 Jul; 31(3):210-7. PubMed ID: 26608163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparable vascular response of a new generation sirolimus eluting stents when compared to fluoropolymer everolimus eluting stents in the porcine coronary restenosis model.
    Buszman PP; Michalak MJ; Pruski M; Fernandez C; Jelonek M; Janas A; Savard C; Gwiazdowska-Nowotka B; Żurakowski A; Wojakowski W; Buszman PE; Milewski K
    Cardiol J; 2016; 23(6):657-666. PubMed ID: 27976797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simple balloon dilation for drug-eluting in-stent restenosis: an optical coherent tomography analysis.
    Arikawa R; Yamaguchi H; Takaoka J; Miyamura A; Atsuchi N; Ninomiya T; Atsuchi Y; Ohishi M; Terashima M; Kaneda H
    Cardiovasc Revasc Med; 2015; 16(1):27-31. PubMed ID: 25578507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between tissue characteristics assessed with optical coherence tomography and mid-term results after percutaneous coronary intervention for in-stent restenosis lesions: a comparison between balloon angioplasty, paclitaxel-coated balloon dilatation, and drug-eluting stent implantation.
    Tada T; Kadota K; Hosogi S; Miyake K; Ohya M; Amano H; Izawa Y; Kanazawa T; Kubo S; Ichinohe T; Hyoudou Y; Hayakawa Y; Sabbah MM; Otsuru S; Hasegawa D; Habara S; Tanaka H; Fuku Y; Katoh H; Goto T; Mitsudo K
    Eur Heart J Cardiovasc Imaging; 2015 Oct; 16(10):1101-11. PubMed ID: 25762559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistant in-stent restenosis in the drug eluting stent era.
    Theodoropoulos K; Mennuni MG; Dangas GD; Meelu OA; Bansilal S; Baber U; Sartori S; Kovacic JC; Moreno PR; Sharma SK; Mehran R; Kini AS
    Catheter Cardiovasc Interv; 2016 Nov; 88(5):777-785. PubMed ID: 27184223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optical coherence tomography findings after chronic total occlusion interventions: Insights from the "AngiographiC evaluation of the everolimus-eluting stent in chronic Total occlusions" (ACE-CTO) study (NCT01012869).
    Sherbet DP; Christopoulos G; Karatasakis A; Danek BA; Kotsia A; Navara R; Michael TT; Roesle M; Rangan BV; Haagen D; Garcia S; Maniu C; Pershad A; Abdullah SM; Hastings JL; Kumbhani DJ; Luna M; Addo T; Banerjee S; Brilakis ES
    Cardiovasc Revasc Med; 2016; 17(7):444-449. PubMed ID: 27133499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optical coherence tomography assessment of in-stent restenosis after percutaneous coronary intervention with two-stent technique in unprotected left main.
    Fujino Y; Attizzani GF; Tahara S; Naganuma T; Takagi K; Yabushita H; Wang W; Warisawa T; Watanabe Y; Mitomo S; Sato T; Kurita N; Ishiguro H; Hozawa K; Nakamura S; Bezerra HG; Nakamura S
    Int J Cardiol; 2016 Sep; 219():285-92. PubMed ID: 27343422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravascular Ultrasound Predictors of Major Adverse Cardiovascular Events After Implantation of Everolimus-eluting Stents for Long Coronary Lesions.
    Lee SY; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Rev Esp Cardiol (Engl Ed); 2017 Feb; 70(2):88-95. PubMed ID: 27789170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serial optical coherence tomography assessment of malapposed struts after everolimus-eluting stent implantation. A subanalysis from the HEAL-EES study.
    Ishida K; Otsuki S; Giacchi G; Ortega-Paz L; Shiratori Y; Freixa X; Martín-Yuste V; Masotti M; Sabaté M; Brugaletta S
    Cardiovasc Revasc Med; 2017; 18(1):47-52. PubMed ID: 27634493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease: the EXECUTIVE trial (EXecutive RCT: evaluating XIENCE V in a multi vessel disease).
    Ribichini F; Romano M; Rosiello R; La Vecchia L; Cabianca E; Caramanno G; Milazzo D; Loschiavo P; Rigattieri S; Musarò S; Pironi B; Fiscella A; Amico F; Indolfi C; Spaccarotella C; Bartorelli A; Trabattoni D; Della Rovere F; Rolandi A; Beqaraj F; Belli R; Sangiorgio P; Villani R; Berni A; Sheiban I; Lopera Quijada MJ; Cappi B; Ribaldi L; Vassanelli C;
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1012-22. PubMed ID: 24055444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The AngiographiC Evaluation of the Everolimus-Eluting Stent in Chronic Total Occlusion (ACE-CTO) Study.
    Kotsia A; Navara R; Michael TT; Sherbet DP; Roesle M; Christopoulos G; Rangan BV; Haagen D; Garcia S; Maniu C; Pershad A; Abdullah SM; Hastings JL; Kumbhani DJ; Luna M; Addo T; Banerjee S; Brilakis ES
    J Invasive Cardiol; 2015 Sep; 27(9):393-400. PubMed ID: 26332874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in optical coherence tomographic findings and clinical outcomes between excimer laser and cutting balloon angioplasty for focal in-stent restenosis lesions.
    Nishino M; Lee Y; Nakamura D; Yoshimura T; Taniike M; Makino N; Kato H; Egami Y; Shutta R; Tanouchi J; Yamada Y
    J Invasive Cardiol; 2012 Oct; 24(10):478-83. PubMed ID: 23043029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.